Real-World Physician Experience on the Effectiveness of Dizester® Homeopathic Digestive Tonic in Patients with Digestive Complaints: A Post-Marketing Survey
DOI:
https://doi.org/10.48165/ahr.2026.11.1.1Keywords:
Dyspepsia, Digestive complaints, Real world evidence, Physician feedback, Immediate relief, Homeopathic Dizester, Digestive TonicAbstract
Introduction: Functional digestive disorders such as dyspepsia, bloating, and acidity are common and often recurrent, affecting quality of life and increasing healthcare burden. Given the need for well-tolerated therapeutic options, this study aimed to evaluate the real-world effectiveness, speed of action, safety, and physician recommendation of Dizester® Homeopathic Digestive Tonic in managing functional digestive complaints. Materials and Methods: A structured Google Form survey was designed to collect feedback from prescribing physicians across different regions. The questionnaire assessed speed of action, clinical effectiveness (5-point rating scale), adverse effects, and recommendation patterns. Of 222 total respondents, data from 151 prescribing physicians were included for descriptive analysis. Results: The majority of physicians reported early symptomatic improvement, with 48.3% indicating immediate relief and 38.4% observing benefit within 15 days; overall, 94.7% noted improvement within 4 weeks. High effectiveness ratings were observed, as 92.7% assigned scores of 4 or 5, and 99.3% rated the product 3 or above. The formulation demonstrated a favorable tolerability profile, with 99% of respondents reporting no undesirable effects; isolated cases of mild gastric burning were reported but not clearly attributable to treatment. Additionally, 96.7% indicated willingness to recommend the product, and the majority of feedback (85%) was positive or highly positive. Conclusion: Real-world evidence and physician feedback suggest that Dizester® Digestive Tonic is effective, rapidly acting, and well-tolerated in routine clinical practice. The findings support its clinical utility in managing functional digestive complaints and highlight the need for further prospective controlled studies to strengthen the evidence baseReferences
Sperber, A. D. (2021). Epidemiology of IBS and other bowel disorders of gut–brain interaction (DGBI). Alimentary Pharmacology & Therapeutics, 54(S1), 1–1.
Ford, A. C. (2020). Overlap between irritable bowel syndrome and inflammatory bowel disease. Gastroenterology & Hepatology, 16(4), 211.
Ekpanyapong, S., & Reddy, K. R. (2020). Fungal and parasitic infections of the liver. Gastroenterology Clinics, 49(2), 379–410.
Khanna, R., MacDonald, J. K., & Levesque, B. G. (2014). Peppermint oil for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. Journal of Clinical Gastroenterology, 48(6), 505–512.
Mehra, P., Sahoo, A. R., Rajakumar, B. S. J., Singh, J. P., Arya, B. S., Khurana, A., Manchanda, R. K. (2022). Homoeopathic pathogenetic trial of Mentha piperita L.: A multicentric, double-blind, randomized and placebo-controlled trial. Indian Journal of Research in Homoeopathy, 16(1), 3–20.
Badgujar, S. B., Patel, V. V., & Bandivdekar, A. H. (2014). Foeniculum vulgare Mill: A review of its botany, phytochemistry, pharmacology, contemporary application, and toxicology. BioMed Research International, 2014, 842674.
Srinivasan, K. (2018). Cumin (Cuminum cyminum) and black cumin (Nigella sativa) seeds: Traditional uses, chemical constituents, and nutraceutical effects. Food Quality and Safety, 2(1), 1–6.
Mishra, K., & Shahi, S. Medicinal uses of Trachyspermum ammi (L.) and Cuminum cyminum. Journal of Advanced Zoology.
Amin, E. A., Ismail, E., Mahboobeh, R., & Tabandeh, S. (2024). The effect of Cuminum cyminum on the return of bowel motility after abdominal surgery: A triple-blind randomized clinical trial. BMC Complementary Medicine and Therapies, 24(1), 254.
Bairwa, R., Sodha, R. S., & Rajawat, B. S. (2012). Trachyspermum ammi. Pharmacognosy Reviews, 6, 56–60.
DS, A. K. A homoeopathic drug proving of Trachyspermum ammi.
Hu, M. L., Rayner, C. K., Wu, K. L., Chuah, S. K., Tai, W. C., Chou, Y. P., Chiu, Y. C., Chiu, K. W., & Hu, T. H. (2011). Effect of ginger on gastric motility and symptoms of functional dyspepsia. World Journal of Gastroenterology, 17(1), 105.
Deutsch, J. K., Levitt, J., & Hass, D. J. (2020). Complementary and alternative medicine for functional gastrointestinal disorders. American Journal of Gastroenterology, 115(3), 350–364.
Mahendra, P., & Bisht, S. (2012). Ferula asafoetida: Traditional uses and pharmacological activity. Pharmacognosy Reviews, 6, 141–146.
Fior, T., & Saine, A. (2015). Asafoetida: An excerpt from the Materia Medica Pura Project. American Journal of Homeopathic Medicine, 108(2).
Bag, A., Bhattacharyya, S. K., & Chattopadhyay, R. R. (2013). The development of Terminalia chebula Retz. (Combretaceae) in clinical research. Asian Pacific Journal of Tropical Biomedicine, 3(3), 244–252.
Wani, K., Shah, N., Prabhune, A., Jadhav, A., Ranjekar, P., & Kaul-Ghanekar, R. (2016). Evaluating the anticancer activity and nanoparticulate nature of homeopathic preparations of Terminalia chebula. Homeopathy, 105(4), 318–326.
Blackwood, A. L. (1995). A manual of materia medica, therapeutics and pharmacology (Reprint ed.). New Delhi: B. Jain Publishers.
Valavan, R., et al. A compendium of rare and clinically established mother tinctures (6th ed.). Noida: Dr. Willmar Schwabe India Pvt. Ltd.
Bag, A., Bhattacharyya, S. K., Pal, N. K., & Chattopadhyay, R. R. (2012). In vitro antimicrobial potential of Terminalia chebula fruit extracts against multidrug-resistant uropathogens. Asian Pacific Journal of Tropical Biomedicine, 2(3), S1883–S1887.
Hota, D., Srinivasan, A., Panigrahi, M. K., Dalua, S. S., Tiwari, P., & Valavan, R. (2025). A clinical study on the efficacy and safety of poly-herbal formulation in managing functional dyspepsia. Phytomedicine Plus, 5(1), 100671.
Ford, A. C., Sperber, A. D., Corsetti, M., & Camilleri, M. (2020). Irritable bowel syndrome. The Lancet, 396(10263), 1675–1688.
